DE2837168A1
(de)
|
1978-08-25 |
1980-03-06 |
Blutspendedienst Dt Rote Kreuz |
Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
|
US4362661A
(en)
|
1979-08-09 |
1982-12-07 |
Teijin Limited |
Immunoglobulin composition having a high monomer content, and process for production thereof
|
CA1153695A
(en)
|
1979-08-30 |
1983-09-13 |
Syoji Ono |
S-sulfonated immunoglobulin composition having a high monomer content and a process for production thereof
|
US4374763A
(en)
|
1979-09-17 |
1983-02-22 |
Morishita Pharmaceutical Co., Ltd. |
Method for producing gamma-globulin for use in intravenous administration and method for producing a pharmaceutical preparation thereof
|
US4396608A
(en)
|
1981-08-24 |
1983-08-02 |
Cutter Laboratories |
Intravenously injectable immune serum globulin
|
US5702699A
(en)
|
1982-09-23 |
1997-12-30 |
Cetus Corporation |
Process for the recovery of lipophilic proteins
|
US4681713A
(en)
|
1984-03-15 |
1987-07-21 |
Toyo Boseki Kabushiki Kaisha |
Method of making a hollow fiber membrane for dialysis
|
US4597966A
(en)
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
US6673347B1
(en)
|
1986-04-30 |
2004-01-06 |
Gryphon Therapeutics |
Polypeptide and protein derivatives and process for their preparation
|
GB8628104D0
(en)
|
1986-11-25 |
1986-12-31 |
Connaught Lab |
Pasteurization of immunoglobin solutions
|
DE3640513A1
(de)
|
1986-11-27 |
1988-06-09 |
Biotest Pharma Gmbh |
Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
|
JP2547556B2
(ja)
|
1987-02-06 |
1996-10-23 |
株式会社 ミドリ十字 |
r−グロブリンの液状製剤
|
AU643427B2
(en)
|
1988-10-31 |
1993-11-18 |
Immunex Corporation |
Interleukin-4 receptors
|
US5395760A
(en)
|
1989-09-05 |
1995-03-07 |
Immunex Corporation |
DNA encoding tumor necrosis factor-α and -β receptors
|
EP0939121B2
(de)
|
1989-09-12 |
2007-12-26 |
AHP Manufacturing B.V. |
TFN-bindende Proteine
|
DE3939346A1
(de)
|
1989-11-29 |
1991-06-06 |
Behringwerke Ag |
Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
|
US5945098A
(en)
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
US5177194A
(en)
|
1990-02-01 |
1993-01-05 |
Baxter International, Inc. |
Process for purifying immune serum globulins
|
GB9017002D0
(en)
|
1990-08-02 |
1990-09-19 |
Health Lab Service Board |
Improved method for the purification of erwina l-asparaginase
|
JP3179538B2
(ja)
|
1990-12-11 |
2001-06-25 |
ノバルティス アクチエンゲゼルシャフト |
安定なヒトカルシトニンの水性溶液
|
US5110910A
(en)
|
1991-03-25 |
1992-05-05 |
Miles Inc. |
Virucidal euglobulin precipitation
|
US5256571A
(en)
|
1991-05-01 |
1993-10-26 |
Cytyc Corporation |
Cell preservative solution
|
ES2179824T3
(es)
|
1991-12-20 |
2003-02-01 |
Yamanouchi Pharma Co Ltd |
Anticuerpos humanizados reactivos contra el antigeno gpiib/iiia.
|
US6004555A
(en)
|
1992-03-05 |
1999-12-21 |
Board Of Regents, The University Of Texas System |
Methods for the specific coagulation of vasculature
|
US5298410A
(en)
|
1993-02-25 |
1994-03-29 |
Sterling Winthrop Inc. |
Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
|
US5484892A
(en)
|
1993-05-21 |
1996-01-16 |
Dana-Farber Cancer Institute, Inc. |
Monoclonal antibodies that block ligand binding to the CD22 receptor in mature B cells
|
DE4344824C1
(de)
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
GB9401448D0
(en)
|
1994-01-26 |
1994-03-23 |
Ciba Geigy Ag |
Stable dry powders
|
US5580856A
(en)
|
1994-07-15 |
1996-12-03 |
Prestrelski; Steven J. |
Formulation of a reconstituted protein, and method and kit for the production thereof
|
CA2195557C
(en)
|
1994-08-12 |
2006-10-17 |
Shui-On Leung |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
BRPI9715219B8
(pt)
|
1996-02-09 |
2015-07-07 |
Abbvie Biotechnology Ltd |
Vetor recombinante de expressão, e célula hospedeira procariótica.
|
TWI240627B
(en)
|
1996-04-26 |
2005-10-01 |
Chugai Pharmaceutical Co Ltd |
Erythropoietin solution preparation
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
TW555765B
(en)
|
1996-07-09 |
2003-10-01 |
Amgen Inc |
Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
|
CA2261291A1
(en)
|
1996-07-18 |
1998-01-29 |
Csl Limited |
Pasteurization of immunoglobulin solutions
|
TW491855B
(en)
|
1996-08-07 |
2002-06-21 |
Csl Ltd |
Purification of immunoglobulins
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
US5886154A
(en)
|
1997-06-20 |
1999-03-23 |
Lebing; Wytold R. |
Chromatographic method for high yield purification and viral inactivation of antibodies
|
JP3679406B2
(ja)
|
1998-05-20 |
2005-08-03 |
協和醗酵工業株式会社 |
遺伝子組換え抗体
|
US6436897B2
(en)
|
1998-06-01 |
2002-08-20 |
Celtrix Pharmaceuticals, Inc. |
Pharmaceutical formulations for IGF/IGFBP
|
DK2270044T3
(en)
|
1998-06-09 |
2015-01-26 |
Csl Behring Ag |
Liquid immunoglobulin G (IgG) product
|
US6610206B1
(en)
|
1998-10-20 |
2003-08-26 |
Advanced Renal Technologies |
Buffered compositions for dialysis
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US7294481B1
(en)
|
1999-01-05 |
2007-11-13 |
Immunex Corporation |
Method for producing recombinant proteins
|
SI1149114T1
(sl)
|
1999-02-03 |
2014-08-29 |
Amgen Inc. |
Polipeptidi, vkljuäśeni v imunskem odgovoru
|
CA2369451C
(en)
|
1999-04-08 |
2009-09-22 |
Genentech, Inc. |
Composition based on oppositely-charged polypeptides
|
NZ515380A
(en)
|
1999-04-09 |
2003-10-31 |
Ortho Mcneil Pharm Inc |
Aqueous stable preserved pharmaceutical compositions of erythropoietin
|
US20010021380A1
(en)
|
1999-04-19 |
2001-09-13 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
US20040220103A1
(en)
|
1999-04-19 |
2004-11-04 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
WO2000062790A2
(en)
|
1999-04-19 |
2000-10-26 |
Immunex Corporation |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
AU783306B2
(en)
|
1999-10-04 |
2005-10-13 |
Novartis Vaccines And Diagnostics, Inc. |
Stabilized liquid polypeptide-containing pharmaceutical compositions
|
ATE403437T1
(de)
|
1999-12-14 |
2008-08-15 |
Genentech Inc |
Lfa-1 antagonisten und tnf-alpha antagonisten zur behandlung von rheumatoiden arthritis
|
EP1238077A1
(en)
|
1999-12-16 |
2002-09-11 |
Amgen Inc., |
Tnfr/opg-like molecules and uses thereof
|
BR0108193A
(pt)
|
2000-02-10 |
2003-02-25 |
Wyeth Corp |
Processo para tratamento ou inibição de dano celular ou morte celular
|
IL150755A0
(en)
|
2000-02-16 |
2003-02-12 |
Genentech Inc |
Uses of agonists and antagonists to modulate activity of tnf-related molecules
|
AU2002224555A1
(en)
|
2000-07-25 |
2002-02-05 |
Takeda Chemical Industries Ltd. |
Process for producing recombinant protein
|
JP5490972B2
(ja)
|
2000-08-04 |
2014-05-14 |
中外製薬株式会社 |
タンパク質注射製剤
|
JP5485489B2
(ja)
|
2000-08-11 |
2014-05-07 |
中外製薬株式会社 |
抗体含有安定化製剤
|
SI1324776T2
(en)
|
2000-10-12 |
2018-06-29 |
Genentech, Inc. |
Concentrated protein formulations with reduced viscosity
|
AR031924A1
(es)
|
2000-12-14 |
2003-10-08 |
Fujisawa Pharmaceutical Co |
Anticuerpos anti-cd28 silenciados y el uso de estos
|
US6693173B2
(en)
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
PE20020801A1
(es)
|
2001-01-05 |
2002-09-06 |
Pfizer |
Anticuerpos contra el receptor del factor de crecimiento similar a insulina
|
ES2184594B1
(es)
|
2001-01-17 |
2004-01-01 |
Probitas Pharma Sa |
Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
|
PL374045A1
(en)
|
2001-02-23 |
2005-09-19 |
Immunex Corporation |
Efficient recovery of correctly refolded proteins
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
EP1405331A1
(en)
|
2001-06-25 |
2004-04-07 |
Koninklijke Philips Electronics N.V. |
High-pressure gas discharge lamp and method of manufacturing the same
|
MXPA04000134A
(es)
|
2001-06-26 |
2005-06-06 |
Abgenix Inc |
Anticuerpos para ligandos de osteoprotegerina.
|
ATE531390T1
(de)
*
|
2001-08-23 |
2011-11-15 |
Genmab As |
Interleukin-15-(il-15-)spezifische menschliche antikörper
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
AU2002305767B2
(en)
|
2001-09-20 |
2008-04-10 |
Cornell Research Foundation, Inc. |
Methods and compositions for treating and preventing skin disorders using binding agents specific for PSMA
|
KR100913714B1
(ko)
|
2001-11-08 |
2009-08-24 |
패시트 바이오테크 코포레이션 |
Igg 항체의 안정한 액상 약학 제형물
|
EP1585477A4
(en)
|
2001-11-30 |
2007-06-27 |
Centocor Inc |
ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
MXPA04006053A
(es)
|
2001-12-21 |
2005-03-31 |
Immunex Corp |
Metodos para purificacion de proteina.
|
EP1475101B1
(en)
|
2002-02-14 |
2010-10-27 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing solution pharmaceuticals
|
AU2003215365A1
(en)
|
2002-02-21 |
2003-09-09 |
Duke University |
Treatment methods using anti-cd22 antibodies
|
ES2311094T3
(es)
|
2002-02-27 |
2009-02-01 |
Immunex Corporation |
Composicion estabilizada de tnfr-fc que comprende arginina.
|
AU2003220529B2
(en)
|
2002-03-27 |
2006-09-07 |
Immunex Corporation |
Methods for increasing polypeptide production
|
AU2003243139B2
(en)
|
2002-04-05 |
2007-06-21 |
Amgen Inc. |
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
|
US20030206898A1
(en)
|
2002-04-26 |
2003-11-06 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
WO2003102132A2
(en)
|
2002-04-26 |
2003-12-11 |
Genetech, Inc. |
Non-affinity purification of proteins
|
GB0210121D0
(en)
|
2002-05-02 |
2002-06-12 |
Celltech R&D Ltd |
Biological products
|
CN1671741A
(zh)
|
2002-06-21 |
2005-09-21 |
拜奥根Idec公司 |
浓缩抗体的缓冲剂制剂及其使用方法
|
KR20150043568A
(ko)
|
2002-07-19 |
2015-04-22 |
애브비 바이오테크놀로지 리미티드 |
TNFα 관련 질환의 치료
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
JP4500683B2
(ja)
|
2002-11-01 |
2010-07-14 |
バイエル・ヘルスケア・エルエルシー |
巨大分子濃縮方法
|
US20040086532A1
(en)
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
MXPA05006521A
(es)
|
2002-12-20 |
2005-08-26 |
Amgen Inc |
Agentes de enlace que inhiben miostatina.
|
CA2518980A1
(en)
|
2003-03-14 |
2004-09-30 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
AU2004229335C1
(en)
|
2003-04-04 |
2010-06-17 |
Genentech, Inc. |
High concentration antibody and protein formulations
|
WO2004104021A2
(en)
|
2003-05-14 |
2004-12-02 |
Dow Corning Corporation |
Controlled release of active agents utilizing repeat sequence protein polymers
|
WO2004110490A2
(en)
|
2003-06-06 |
2004-12-23 |
Regeneron Pharmaceuticals, Inc. |
Use of vegf inhibitors for tumor regression
|
ES2315664T3
(es)
|
2003-06-30 |
2009-04-01 |
Domantis Limited |
Anticuerpos de dominio unico (dab) pegilados.
|
ATE548388T1
(de)
|
2003-11-07 |
2012-03-15 |
Immunex Corp |
An den interleukin-4-rezeptor bindende antikörper
|
EP1532983A1
(en)
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
CA2555791A1
(en)
|
2004-02-12 |
2005-08-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Highly concentrated liquid formulations of anti-egfr antibodies
|
WO2005095454A1
(en)
|
2004-03-25 |
2005-10-13 |
Diadexus, Inc. |
Lng105 antibody composition and methods of use, and use of lng105 to assess lung cancer risk
|
EP1753404A1
(en)
|
2004-05-12 |
2007-02-21 |
Baxter International Inc. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
JPWO2006003999A1
(ja)
|
2004-07-05 |
2008-07-31 |
財団法人化学及血清療法研究所 |
ヒト抗ヒトb7rp−1抗体およびその抗体フラグメント
|
WO2006012965A1
(de)
*
|
2004-07-29 |
2006-02-09 |
Merck Patent Gmbh |
Difluorsubstitierte heterocyclische verbindungen und deren verwendung als komponenten in flüssigkristallinen medien
|
TW200621282A
(en)
|
2004-08-13 |
2006-07-01 |
Wyeth Corp |
Stabilizing formulations
|
US7300773B2
(en)
|
2004-08-27 |
2007-11-27 |
Wyeth Research Ireland Limited |
Production of TNFR-Ig
|
AU2005279347A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
WO2006064373A2
(en)
|
2004-12-16 |
2006-06-22 |
Genzyme Polyclonals S.A.S. |
Methods of purifying immunologlobulins
|
JP4498939B2
(ja)
|
2005-02-01 |
2010-07-07 |
東京応化工業株式会社 |
ポジ型レジスト組成物およびレジストパターン形成方法
|
US8597709B2
(en)
|
2005-04-12 |
2013-12-03 |
Inovobiologic Inc. |
Dietary supplement and methods of use
|
KR20080031684A
(ko)
|
2005-06-14 |
2008-04-10 |
암젠 인코포레이티드 |
자가 - 완충성 단백질 제형
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
US20070049732A1
(en)
|
2005-09-01 |
2007-03-01 |
Zurlo Eugene J |
Ultra-high yield intravenous immune globulin preparation
|
JP5161779B2
(ja)
|
2005-09-21 |
2013-03-13 |
バーコン ニュートラサイエンス (エムビー) コーポレイション |
等電沈殿を含むキャノーラタンパク質単離物の調製
|
US8067350B2
(en)
|
2005-12-15 |
2011-11-29 |
Kimberly-Clark Worldwide, Inc. |
Color changing cleansing composition
|
US20070202051A1
(en)
|
2006-02-10 |
2007-08-30 |
Pari Gmbh |
Aerosols for sinunasal drug delivery
|
AU2007240732B2
(en)
|
2006-04-21 |
2013-07-04 |
Amgen, Inc. |
Buffering agents for biopharmaceutical formulations
|
KR101317235B1
(ko)
|
2006-04-21 |
2013-10-15 |
조마 테크놀로지 리미티드 |
길항제 항-cd40 항체 제약 조성물
|
JP2010503683A
(ja)
|
2006-09-15 |
2010-02-04 |
バロフォールド, インコーポレイテッド |
免疫原性低下のためのタンパク質の高圧処理
|
NZ613356A
(en)
|
2006-10-27 |
2015-02-27 |
Abbvie Biotechnology Ltd |
Crystalline anti-htnfalpha antibodies
|
EP2129401B8
(en)
|
2006-12-21 |
2020-01-15 |
Amgen Inc. |
Stable buffered formulations containing polypeptides
|
CA2707483A1
(en)
*
|
2007-11-30 |
2009-06-11 |
Wolfgang Fraunhofer |
Protein formulations and methods of making same
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
JP2011519347A
(ja)
*
|
2008-02-07 |
2011-07-07 |
アムジエン・インコーポレーテツド |
安定化されたタンパク質組成物
|
US8177749B2
(en)
|
2008-05-20 |
2012-05-15 |
Avant Medical Corp. |
Cassette for a hidden injection needle
|
US8052645B2
(en)
|
2008-07-23 |
2011-11-08 |
Avant Medical Corp. |
System and method for an injection using a syringe needle
|
JP5836120B2
(ja)
|
2008-05-20 |
2015-12-24 |
アヴァント・メディカル・コーポレーション |
オートインジェクタシステム
|
MX2011003013A
(es)
*
|
2008-09-19 |
2011-04-11 |
Pfizer |
Formulacion liquida estable de anticuerpos.
|
CN104740631B
(zh)
*
|
2008-10-29 |
2019-04-16 |
阿布林克斯公司 |
单域抗原结合性分子的制剂
|
SG174258A1
(en)
|
2009-03-06 |
2011-10-28 |
Genentech Inc |
Antibody formulation
|
US20110070227A1
(en)
|
2009-09-18 |
2011-03-24 |
Anna-Marie Novotney-Barry |
Treatment of Autoimmune and Inflammatory Diseases
|
TWI606840B
(zh)
|
2010-11-11 |
2017-12-01 |
艾伯維生物技術有限責任公司 |
具有增進高濃度之抗-TNFα抗體之液體調配物
|
US9084849B2
(en)
*
|
2011-01-26 |
2015-07-21 |
Kaleo, Inc. |
Medicament delivery devices for administration of a medicament within a prefilled syringe
|
PL2699293T3
(pl)
|
2011-04-20 |
2019-08-30 |
Amgen Inc. |
Urządzenie do wstrzykiwania automatycznego
|
RU2614257C2
(ru)
*
|
2011-04-20 |
2017-03-24 |
Сандоз Аг |
СТАБИЛЬНЫЕ ЖИДКИЕ ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ СЛИТОГО БЕЛКА TNFR:Fc
|
UY34105A
(es)
|
2011-06-03 |
2012-07-31 |
Lg Life Sciences Ltd |
Formulación líquida estable de etanercept
|
AU2012279205B2
(en)
|
2011-07-01 |
2017-08-31 |
Biogen Ma Inc. |
Arginine - free TNFR : Fc- fusion polypeptide compositions and methods of use
|
KR20140079491A
(ko)
|
2011-10-18 |
2014-06-26 |
코히러스 바이오사이언시즈, 인코포레이티드 |
당과 폴리올과의 배합물로 안정화된 에타너셉트 제형
|
EP2863951A1
(en)
*
|
2012-06-12 |
2015-04-29 |
Boehringer Ingelheim International GmbH |
Pharmaceutical formulation for a therapeutic antibody
|
EP2869871B1
(en)
|
2012-07-05 |
2021-03-17 |
UNL Holdings LLC |
Automatic injectors for injectable cartridges and drive control mechanisms therefor
|
AU2013290289B2
(en)
*
|
2012-07-09 |
2018-03-29 |
Coherus Biosciences, Inc. |
Etanercept formulations exhibiting marked reduction in sub-visible particles
|
EP2895188B1
(en)
*
|
2012-09-11 |
2017-11-15 |
Coherus Biosciences, Inc. |
Correctly folded etanercept in high purity and excellent yield
|
BR112015009462A2
(pt)
*
|
2012-10-26 |
2017-07-04 |
Lupin Atlantis Holdings Sa |
composição farmacêutica estável do tnfr:fc proteína de fusão
|
US9649383B2
(en)
|
2012-11-19 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Liquid formulations for TNFR:Fc fusion proteins
|
WO2014084508A1
(ko)
*
|
2012-11-27 |
2014-06-05 |
(주)알테오젠 |
단백질과 Fc 도메인을 융합한 융합 단백질의 안정화용 조성물
|
AR094458A1
(es)
|
2012-12-06 |
2015-08-05 |
Iams Co |
Alimento con formas perceptibles para mascotas
|
WO2014106116A2
(en)
|
2012-12-28 |
2014-07-03 |
Abbott Cardiovascular Systems Inc. |
Delivery of biologic therapeutics
|
US10092703B2
(en)
|
2013-03-15 |
2018-10-09 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
EP3593839A1
(en)
|
2013-03-15 |
2020-01-15 |
Amgen Inc. |
Drug cassette
|
BR112015027764A2
(pt)
*
|
2013-05-02 |
2017-08-29 |
Mabxience S A |
Formulações alternativas para os polipeptídeos de fusão de tnfr: fc
|
CN113350278B
(zh)
*
|
2013-10-24 |
2023-03-24 |
阿斯利康(瑞典)有限公司 |
稳定的水性抗体配制品
|
KR101712245B1
(ko)
*
|
2013-11-29 |
2017-03-06 |
아레스 트레이딩 에스.에이. |
TNFR 및 면역글로블린 Fc 영역을 포함하는 융합 단백질을 포함하는 액상 제제
|
ES2733298T3
(es)
|
2014-07-18 |
2019-11-28 |
Sandoz Ag |
Cuantificación de TNFR2:Fc plegado erróneamente
|
EP3185934B1
(en)
|
2014-08-28 |
2018-06-20 |
UNL Holdings LLC |
Skin sensors for drug delivery devices
|
ES2834023T3
(es)
|
2014-08-28 |
2021-06-16 |
Unl Holdings Llc |
Sistemas de sensores para dispositivos de administración de fármacos
|
BR112017013269A2
(pt)
*
|
2014-12-22 |
2018-02-27 |
Ares Trading S.A. |
?composição farmacêutica líquida?
|
EP3268042A4
(en)
|
2015-03-13 |
2018-08-01 |
Samsung Bioepis Co., Ltd. |
Anti-tnf-alpha polypeptide composition and use thereof
|
US9763976B1
(en)
|
2016-08-02 |
2017-09-19 |
Zo Skin Health, Inc. |
Composition and method for treating skin conditions
|
BR112019007858A2
(pt)
|
2016-10-21 |
2019-07-02 |
Amgen Inc |
formulações farmacêuticas e métodos para produzir as mesmas
|